{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T20:26:29Z","timestamp":1782937589190,"version":"3.54.5"},"reference-count":23,"publisher":"Japanese Society of Internal Medicine","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2018,6,15]]},"DOI":"10.2169\/internalmedicine.0215-17","type":"journal-article","created":{"date-parts":[[2018,1,10]],"date-time":"2018-01-10T22:15:16Z","timestamp":1515622516000},"page":"1783-1788","source":"Crossref","is-referenced-by-count":21,"title":["Peripheral Ulcerative Keratitis Associated with Granulomatosis with Polyangiitis Emerging Despite Cyclophosphamide, Successfully Treated with Rituximab"],"prefix":"10.2169","volume":"57","author":[{"given":"Yuya","family":"Fujita","sequence":"first","affiliation":[{"name":"Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoichi","family":"Fukui","sequence":"additional","affiliation":[{"name":"Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Japan"},{"name":"Department of Community Medicine, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yushiro","family":"Endo","sequence":"additional","affiliation":[{"name":"Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sosuke","family":"Tsuji","sequence":"additional","affiliation":[{"name":"Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayuko","family":"Takatani","sequence":"additional","affiliation":[{"name":"Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshimasa","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masataka","family":"Umeda","sequence":"additional","affiliation":[{"name":"Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Japan"},{"name":"Medical Education Development Center, Nagasaki University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayako","family":"Nishino","sequence":"additional","affiliation":[{"name":"Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Japan"},{"name":"Center for Comprehensive Community Care Education Medicine, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Koga","sequence":"additional","affiliation":[{"name":"Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Japan"},{"name":"Center for Bioinformatics and Molecular Medicine, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin-ya","family":"Kawashiri","sequence":"additional","affiliation":[{"name":"Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Japan"},{"name":"Department of Community Medicine, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Iwamoto","sequence":"additional","affiliation":[{"name":"Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunihiro","family":"Ichinose","sequence":"additional","affiliation":[{"name":"Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mami","family":"Tamai","sequence":"additional","affiliation":[{"name":"Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoki","family":"Origuchi","sequence":"additional","affiliation":[{"name":"Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Japan"},{"name":"Department of Rehabilitation Sciences, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryotaro","family":"Ueki","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Uematsu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaori","family":"Ishida","sequence":"additional","affiliation":[{"name":"Department of Pathology, Nagasaki University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuniko","family":"Abe","sequence":"additional","affiliation":[{"name":"Department of Pathology, Nagasaki University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Kawakami","sequence":"additional","affiliation":[{"name":"Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Falk RJ, Gross WL, Guillevin L, et al. Granulomatosis with polyangiitis (Wegener&apos;s): an alternative name for Wegener&apos;s granulomatosis. Arthritis Rheum 63: 863-864, 2011.","DOI":"10.1002\/art.30286"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Woywodt A, Haubitz M, Haller H, Matteson EL. Wegener&apos;s granulomatosis. Lancet 367: 1362-1366, 2006.","DOI":"10.1016\/S0140-6736(06)68583-8"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Pakrou N, Selva D, Leibovitch I. Wegener&apos;s granulomatosis: ophthalmic manifestations and management. Semin Arthritis Rheum 35: 284-292, 2006.","DOI":"10.1016\/j.semarthrit.2005.12.003"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Jennette JC, Falk RJ, Bacon PA, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 65: 1-11, 2013.","DOI":"10.1002\/art.37715"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Watts R, Lane S, Hanslik T, et al. Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis 66: 222-227, 2007.","DOI":"10.1136\/ard.2006.054593"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Watkins AS, Kempen JH, Choi D, et al. Ocular disease in patients with ANCA-positive vasculitis. J Ocul Biol Dis Infor 3: 12-19, 2010.","DOI":"10.1007\/s12177-009-9044-4"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Keogh KA, Ytterberg SR, Fervenza FC, Carlson KA, Schroeder DR, Specks U. Rituximab for refractory Wegener&apos;s granulomatosis: report of a prospective, open-label pilot trial. Am J Respir Crit Care Med 173: 180-187, 2006.","DOI":"10.1164\/rccm.200507-1144OC"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Specks U, Fervenza FC, McDonald TJ, Hogan MC. Response of Wegener&apos;s granulomatosis to anti-CD20 chimeric monoclonal antibody therapy. Arthritis Rheum 44: 2836-2840, 2001.","DOI":"10.1002\/1529-0131(200112)44:12<2836::AID-ART471>3.0.CO;2-W"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Reinhold-Keller E, Kekow J, Schnabel A, et al. Influence of disease manifestation and antineutrophil cytoplasmic antibody titer on the response to pulse cyclophosphamide therapy in patients with Wegener&apos;s granulomatosis. Arthritis Rheum 37: 919-924, 1994.","DOI":"10.1002\/art.1780370622"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Onal S, Kazokoglu H, Ko\u00e7 A, Yavuz S. Rituximab for remission induction in a patient with relapsing necrotizing scleritis associated with limited Wegener&apos;s granulomatosis. Ocul Immunol Inflamm 16: 230-232, 2008.","DOI":"10.1080\/09273940802331643"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Taylor SR, Salama AD, Joshi L, Pusey CD, Lightman SL. Rituximab is effective in the treatment of refractory ophthalmic Wegener&apos;s granulomatosis. Arthritis Rheum 60: 1540-1547, 2009.","DOI":"10.1002\/art.24454"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Huerva V, Sanchez MC, Traveset A, Jurjo C, Ruiz A. Rituximab for peripheral ulcerative keratitis with Wegener granulomatosis. Cornea 29: 708-710, 2010.","DOI":"10.1097\/ICO.0b013e3181c296ed"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Lower EE, Baughman RP, Kaufman AH. Rituximab for refractory granulomatous eye disease. Clin Ophthalmol 6: 1613-1618, 2012.","DOI":"10.2147\/OPTH.S35521"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Recillas-Gispert C, Serna-Ojeda JC, Flores-Su\u00e1rez LF. Rituximab in the treatment of refractory scleritis in patients with granulomatosis with polyangiitis (Wegener&apos;s). Graefe&apos;s Arch Clin Exp Ophthalmol 253: 2279-2284, 2015.","DOI":"10.1007\/s00417-015-3198-5"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Jones RB, Ferraro AJ, Chaudhry AN, et al. A multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 60: 2156-2168, 2009.","DOI":"10.1002\/art.24637"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Charles SJ, Meyer PA, Watson PG. Diagnosis and management of systemic Wegener&apos;s granulomatosis presenting with anterior ocular inflammatory disease. Br J Ophthalmol 75: 201-207, 1991.","DOI":"10.1136\/bjo.75.4.201"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Ahmed M, Niffenegger JH, Jakobiec FA, et al. Diagnosis of limited ophthalmic Wegener granulomatosis: distinctive pathologic features with ANCA test confirmation. Int Ophthalmol 28: 35-46, 2008.","DOI":"10.1007\/s10792-007-9109-y"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Aouba A, Pagnoux C, Bienvenu B, Mahr A, Guillevin L. Analysis of Wegener&apos;s granulomatosis responses to rituximab: current evidence and therapeutic prospects. Clin Rev Allergy Immunol 34: 65-73, 2008.","DOI":"10.1007\/s12016-007-8026-1"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Holle JU, Dubrau C, Herlyn K, et al. Rituximab for refractory granulomatosis with polyangiitis (Wegener&apos;s granulomatosis): comparison of efficacy in granulomatous versus vasculitic manifestations. Ann Rheum Dis 71: 327-333, 2012.","DOI":"10.1136\/ard.2011.153601"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Rajendram R, Fraser-Bell S, Kaines A, et al. A 2-year prospective randomized controlled trial of intravitreal bevacizumab or laser therapy (BOLT) in the management of diabetic macular edema: 24-month data: report 3. Arch Ophthalmol 130: 972-979, 2012.","DOI":"10.1001\/archophthalmol.2012.393"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Fung AE, Rosenfeld PJ, Reichel E. The International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwide. Br J Ophthalmol 90: 1344-1349, 2006.","DOI":"10.1136\/bjo.2006.099598"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Tseng SC. Amniotic membrane transplantation for ocular surface reconstruction. Biosci Rep 21: 481-489, 2001.","DOI":"10.1023\/A:1017995810755"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Jia Y, Gao H, Li S, Shi W. Combined anterior chamber washout, amniotic membrane transplantation, and topical use of corticosteroids for severe peripheral ulcerative keratitis. Cornea 33: 559-564, 2014.","DOI":"10.1097\/ICO.0000000000000130"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/12\/57_0215-17\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,9]],"date-time":"2019-10-09T06:50:30Z","timestamp":1570603830000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/12\/57_0215-17\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,15]]},"references-count":23,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.0215-17","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,15]]}}}